acquired
Stage
2
Investors
About
Seqens is an integrated global provider of pharmaceutical synthesis and specialty ingredients, operating manufacturing sites and R&D centers across Europe, North America and Asia. It develops custom chemical solutions and ingredients for customers in healthcare, electronics, cosmetics, food and homecare.
Explore Seqens's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.